SCHEMBL755344

SCHEMBL755344

Cc1nc(N)cc(-c2c(Cl)nc3ccc(Br)cn23)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.40
MTOR P42345 5/20 0.40
APP P05067 1/20 0.37
PIK3CG P48736 1/20 0.37
GAA P10253 2/20 0.36
MAP3K14 Q99558 3/20 0.36
PIK3CD O00329 1/20 0.36
PIK3R1 P27986 1/20 0.36
EPHB3 P54753 1/20 0.34
TRPA1 O75762 1/20 0.34
TSHR P16473 1/20 0.33
MAPK10 P53779 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
NFKB1 P19838 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL753757 0.87 GAA (0.38) PIK3CAMTORAPPGAAMAP3K14
SCHEMBL753913 0.79 PIK3CA (0.60) PIK3CAMTORGAAMEN1NPC1
SCHEMBL757760 0.78 PIK3CA (0.43) PIK3CAMTORGAAMAP3K14PIK3CD
SCHEMBL22519218 0.71 GAA (0.47) PIK3CAMTORAPPPIK3CGGAA
SCHEMBL753575 0.70 PIK3CA (0.62) PIK3CAMTOR
SCHEMBL751865 0.68 PIK3CA (0.39) PIK3CAMTORPIK3CGPIK3CD
SCHEMBL31547246 0.66 RXFP1 (0.48) PIK3CAMTORGAAEPHB3TRPA1
SCHEMBL18760037 0.65 PIK3CG (0.51) PIK3CGGAAMAP3K14TSHRMAPK10
SCHEMBL24616873 0.65 TSHR (0.44) PIK3CGGAAMAP3K14EPHB3TRPA1
SCHEMBL22519225 0.61 PSD (0.40) GAAEPHB3TRPA1TSHRMAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430013-B1 HETEROARYL COMPOUNDS AS PIKK INHIBITORS AMGEN INC (US) 2014-10-15 EP disclosed
US-20120190666-A1 Heteroaryl Compounds as PIKK Inhibitors AMGEN INC. (US) 2012-07-26 US disclosed
EP-2430013-A1 HETEROARYL COMPOUNDS AS PIKK INHIBITORS Amgen, Inc (US) 2012-03-21 EP disclosed
WO-2010132598-A1 HETEROARYL COMPOUNDS AS PIKK INHIBITORS AMGEN INC. (US) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190666-A1 Heteroaryl Compounds as PIKK Inhibitors PIK3CA, PIKFYVE, PIK3CD PIK3CA 1/4885MTOR 21/4885APP 4224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.